Youcare Pharmaceutical Group Co (SHSE:688658) Long-Term Debt: ¥475 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688658 Youcare Pharmaceutical Group Co Ltd SHSE:688658
54 GF Score
Price ¥13.84
GF Value ¥11.80
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Youcare Pharmaceutical Group Co Long-Term Debt?

Youcare Pharmaceutical Group Co SHSE:688658 +3.21% 54 Long-Term Debt is ¥475 Mil as of Jun. 2026. GuruFocus rates SHSE:688658 with a GF Score™ of 54/100 and a GF Value™ of ¥11.80 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Youcare Pharmaceutical Group Co's Long-Term Debt for the quarter that ended in Jun. 2026 was ¥475 Mil.

Youcare Pharmaceutical Group Co's quarterly Long-Term Debt increased from Dec. 2025 (¥78 Mil) to Mar. 2026 (¥492 Mil) but then declined from Mar. 2026 (¥492 Mil) to Jun. 2026 (¥475 Mil).

Youcare Pharmaceutical Group Co's annual Long-Term Debt increased from Dec. 2023 (¥55 Mil) to Dec. 2024 (¥517 Mil) but then declined from Dec. 2024 (¥517 Mil) to Dec. 2025 (¥78 Mil).

Youcare Pharmaceutical Group Co  (SHSE:688658) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Youcare Pharmaceutical Group Co Long-Term Debt Related Terms

Youcare Pharmaceutical Group Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Youcare Pharmaceutical Group Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Youcare Pharmaceutical Group Co Long-Term Debt Chart

Youcare Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 54.57 516.97 77.51

Youcare Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 343.05 299.91 77.51 492.07 474.54
SHSE:688658
54GF Score
Youcare Pharmaceutical Group Co Ltd SHSE:688658
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ¥475 Mil mean?
Youcare Pharmaceutical Group Co (SHSE:688658) has a Long-Term Debt of ¥475 Mil as of Jun. 2026.
Is Youcare Pharmaceutical Group Co's Long-Term Debt too high?
Youcare Pharmaceutical Group Co's current Long-Term Debt is ¥475 Mil. Overall, Youcare Pharmaceutical Group Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Youcare Pharmaceutical Group Co's Long-Term Debt compare to VRTX and REGN?
Youcare Pharmaceutical Group Co's Long-Term Debt of ¥475 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Youcare Pharmaceutical Group Co's current Long-Term Debt is ¥475 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Youcare Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co (SHSE:688658) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥11.80, compared to a current price of ¥13.84 — trading 17.3% above its estimated fair value. The current Long-Term Debt is ¥475 Mil. Youcare Pharmaceutical Group Co's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Youcare Pharmaceutical Group Co (SHSE:688658), the current Long-Term Debt is ¥475 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Youcare Pharmaceutical Group Co (SHSE:688658) Overvalued in 2026?

Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥13.84 is trading 17.3% above its estimated GF Value™ of ¥11.80. GuruFocus considers Youcare Pharmaceutical Group Co to be Modestly Overvalued.

Key valuation signals for SHSE:688658:

  • Long-Term Debt: ¥475 Mil
  • GF Value™: ¥11.80 vs. price of ¥13.84 (17.3% above fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Youcare Pharmaceutical Group Co Business Description

Address No. 6, Hongda Middle Road, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Youcare Pharmaceutical Group Co Ltd is a Chinese pharmaceutical company engaged in the research, development, production, and commercialization of chemical drugs, with a focus on high-end generic formulations and specialty pharmaceuticals. Its product portfolio spans therapeutic areas including oncology, cardiovascular, anti-infective, and central nervous system treatments, and the company emphasizes complex and differentiated dosage forms such as injectables and sustained-release formulations. Youcare serves hospitals, medical institutions, and pharmaceutical distributors across China, with its primary market being the domestic healthcare sector. Revenue is generated mainly through the sale of its pharmaceutical products, supported by ongoing investment in research and development and a pipeline of new drug candidates. The company operates manufacturing facilities in China and continues to expand its product offerings through internal development and regulatory approvals.
54GF Score

Get the complete analysis for SHSE:688658

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥13.84
Price
¥11.80
GF Value